« Back to Record
Moretti, E., Desmedt, C., Biagioni, C., Regan, M. M., Oakman, C., Larsimont, D., Galardi, F., Piccart-Gebhart, M., Sotiriou, C., Rimm, D. D., & Di Leo, A. (2013). TOP2A protein by quantitative immunofluorescence as a predictor of response to epirubicin in the neoadjuvant treatment of breast cancer. Future oncology, 9(10), 1477-1487. doi:10.2217/fon.13.103
Citation APA
Permalink
Permalink
http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/153435



